These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 10684216)
21. Changes in lipid metabolism and antioxidant defense status in spontaneously hypertensive rats and Wistar rats fed a diet enriched with fructose and saturated fatty acids. Girard A; Madani S; El Boustani ES; Belleville J; Prost J Nutrition; 2005 Feb; 21(2):240-8. PubMed ID: 15723754 [TBL] [Abstract][Full Text] [Related]
22. Changes in serum lipids and antioxidant status in west Algerian patients with essential hypertension treated with acebutolol compared to healthy subjects. Krouf D; Bouchenak M; Mohammedi B; Cherrad A; Belleville JL; Prost JL Med Sci Monit; 2003 Aug; 9(8):PI109-15. PubMed ID: 12942043 [TBL] [Abstract][Full Text] [Related]
23. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study. Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306 [TBL] [Abstract][Full Text] [Related]
24. [Characteristics of the antioxidant activity of the blood plasma in patients with hypertension]. Siurin AA; Kulagin IuI; Sorkina DA; Shvets NI; Mostovoĭ VP; Krutikova IV Vrach Delo; 1990 Jan; (1):67-9. PubMed ID: 2330717 [TBL] [Abstract][Full Text] [Related]
25. [Activity of intracellular antioxidant enzymes in hypertensive patients]. El'chaninova SA; Galaktionova LP; Tolmacheva NV; Varshavskiĭ BIa Ter Arkh; 2000; 72(4):51-3. PubMed ID: 10833800 [TBL] [Abstract][Full Text] [Related]
26. [The antioxidant effects of emoxipin in patients with iron-deficiency anemia]. Shved MI; Palamar TO Lik Sprava; 1995; (9-12):72-5. PubMed ID: 8983799 [TBL] [Abstract][Full Text] [Related]
27. [Features of arterial hypertension course in north regions of the country]. Zapesochnaia IL; Avtandilov AG Klin Med (Mosk); 2008; 86(5):42-4. PubMed ID: 18589717 [TBL] [Abstract][Full Text] [Related]
28. [The significance of the antioxidant properties of emoxipin in the combined treatment of patients with chronic heart failure]. Rudyk BI; Sabadyshin RA Lik Sprava; 1992 Apr; (4):25-8. PubMed ID: 1441362 [TBL] [Abstract][Full Text] [Related]
29. [Daily profile of arterial pressure in patients with arterial hypertension, continuously living in Tyumen polar region]. Gapon LI; Sereda TV; Shurkevich NP; Shanaurina NV Ter Arkh; 2003; 75(1):37-40. PubMed ID: 12652954 [TBL] [Abstract][Full Text] [Related]
30. [Blood lipid spectrum in hypertensive patients and normotensive subjects living in the Khanty-Mansiysk region]. Mikhaĭlova IM; Gapon LI; Belousov VV; Startseva ON; Alekseeva SV Ter Arkh; 2009; 81(9):17-9. PubMed ID: 19827646 [TBL] [Abstract][Full Text] [Related]
31. Adaptive changes of membrane lipid composition in humans living in the north. Marachev A; Solovenchuk L; Lapinski A Arctic Med Res; 1992 Apr; 51(2):98-102. PubMed ID: 1622534 [TBL] [Abstract][Full Text] [Related]
32. Oral antioxidants and cardiovascular health in the exercise-trained and untrained elderly: a radically different outcome. Wray DW; Uberoi A; Lawrenson L; Bailey DM; Richardson RS Clin Sci (Lond); 2009 Mar; 116(5):433-41. PubMed ID: 18795893 [TBL] [Abstract][Full Text] [Related]
33. [The effectiveness of ascorbic acid and emoxipin in treatment of infiltrative pulmonary tuberculosis]. Volchegorskiĭ IA; Novoselov PN; Astakhova TV Klin Med (Mosk); 2007; 85(12):55-8. PubMed ID: 18318169 [TBL] [Abstract][Full Text] [Related]
34. Decrease in oxidative stress through supplementation of vitamins C and E is associated with a reduction in blood pressure in patients with essential hypertension. Rodrigo R; Prat H; Passalacqua W; Araya J; Bächler JP Clin Sci (Lond); 2008 May; 114(10):625-34. PubMed ID: 17999638 [TBL] [Abstract][Full Text] [Related]
35. Antioxidant activity of propionyl-L-carnitine in liver and heart of spontaneously hypertensive rats. Gómez-Amores L; Mate A; Revilla E; Santa-María C; Vázquez CM Life Sci; 2006 Mar; 78(17):1945-52. PubMed ID: 16263137 [TBL] [Abstract][Full Text] [Related]
36. Comparison of valsartan/hydrochlorothiazide combination therapy at doses up to 320/25 mg versus monotherapy: a double-blind, placebo-controlled study followed by long-term combination therapy in hypertensive adults. Pool JL; Glazer R; Weinberger M; Alvarado R; Huang J; Graff A Clin Ther; 2007 Jan; 29(1):61-73. PubMed ID: 17379047 [TBL] [Abstract][Full Text] [Related]
37. [Lipid peroxidation in patients with hypertension and chronic pyelonephritis with arterial hypertension]. Siurin AA; Kulagin IuI; Kuznetsov NS; Prokhoda AF; Gets NP; Vyborova VA Klin Med (Mosk); 1990 Dec; 68(12):20-2. PubMed ID: 2084329 [TBL] [Abstract][Full Text] [Related]
38. Reactive oxygen species and antioxidant status in essential arterial hypertension during therapy with dihydropyridine calcium channel antagonists. Digiesi V; Fiorillo C; Cosmi L; Rossetti M; Lenuzza M; Guidi D; Pace S; Rizzuti G; Nassi P Clin Ter; 2000; 151(1):15-8. PubMed ID: 10822876 [TBL] [Abstract][Full Text] [Related]
39. [Clinical efficacy of combined therapy with enalapril + trimetazidine in patients with hypertension comorbid with ischemic heart disease and metabolic disturbances]. Petelina TI; Gapon LI; Bakhmatova IuA; Zhevagina IA Ter Arkh; 2005; 77(8):19-23. PubMed ID: 16206600 [TBL] [Abstract][Full Text] [Related]
40. [The laser therapy of hypertension patients in the initial stages]. Velizhanina IA; Shabalina MS; Gapon LI; Kamalova NN; Sergeĭchik OI Vopr Kurortol Fizioter Lech Fiz Kult; 1998; (1):9-11. PubMed ID: 9560992 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]